The ACR Government Affairs Committee has developed legislative language to limit commercial insurance plans’ cost-sharing requirements for medications in a specialty drug tier to the dollar amount applicable to drugs in the nonpreferred-brand drug tier.
Coding Corner Question: August Coding Challenge
A 43-year-old female established patient diagnosed with rheumatoid arthritis comes to the office for her first infliximab infusion.
EULAR 2012: Systemic Sclerosis That Doesn’t Fit the Mold
This disease presents a range of hard-to-solve clinical difficulties.
Where the Presidential Candidates Stand on Key Healthcare Issues
Where President Obama and and Republican presidential candidate Mitt Romney stand on healthcare issues affecting rheumatologists and the medical profession as a whole.
Drug Updates: EULAR 2012
Tracking the results of drug safety and efficacy
Letter: No European Consensus on Steroid Use in Rheumatoid Arthritis
There is not a consensus between all European rheumatologists regarding the use of steroids in RA; quite a few share your skepticism, including myself.
Inflammatory Myopathies in Children
Treatment options and recent research for juvenile dermatomyositis.
California Rheumatologists Explore Managed Care, Treatment Options
Advances in SLE, osteoporosis, and RA highlighted at California Rheumatology Alliance meeting.
Drug Updates
Information on new approvals and medication safety.
The Complexity of Lumbar Spinal Stenosis
Challenges in diagnosis and management.
- « Previous Page
- 1
- …
- 14
- 15
- 16
- 17
- 18
- …
- 21
- Next Page »